Followers | 66 |
Posts | 4898 |
Boards Moderated | 0 |
Alias Born | 06/12/2014 |
Wednesday, November 13, 2019 4:14:45 PM
"We certainly see 2019 as a year of commercialization. As I mentioned, we’re working on 510(k) filings and commercialization strategy will align with these specific indications for use. At the same time, we continue development of our technology platform that will focus on other indications that have
and we will continue to evaluate and refine that business model."
https://medicalalley.org/2019/01/6-questions-on-the-future-of-healthcare-with-david-kaysen/?preview=true&_thumbnail_id=130652&utm_source=newsletter&utm_medium=Email&utm_campaign=Jan21
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM